A Phase 2a, Open-Label Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DISC-3405 in Participants with Polycythemia Vera (PV
Clinical Trial Grant
Awarded By
Disc Medicine Inc.
Start Date
July 28, 2025
End Date
July 31, 2030
Awarded By
Disc Medicine Inc.
Start Date
July 28, 2025
End Date
July 31, 2030